Dual intracellular targeting by ruxolitinib and Mcl-1 inhibitor S63845 in IL-6 dependent myeloma cells blocks in vivo tumor growth

Renate Burger, Anna Otte, Jan Brdon, Matthias Peipp, Martin Gramatzki
2021 Haematologica  
Not available.
doi:10.3324/haematol.2020.276865 pmid:33882638 pmcid:PMC8409037 fatcat:hmkz4vi2szc3dpiytxvjacwojq